Kate June 30, 2024 A patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases.
Tmunity June 30, 2024 Tmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell therapy to treat and potentially cure